What are the latest advances shaping breast cancer treatment? Dr. Ruth O’Regan, Deputy Editor and Breast Disease Section Editor for Cancer, speaks with Dr. Kevin Kalinsky about his recent commentary highlighting efforts to reduce treatment intensity, the role of biomarkers in personalizing care, and emerging therapies such as antibody–drug conjugates.
Read the featured commentary, “Top advances of the year: Breast cancer”: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.70572'>https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.70572</a>
Follow Cancer on social media:
<a href='https://x.com/JournalCancer'>x.com/JournalCancer</a> 
<a href='https://www.instagram.com/acsjournals/'>instagram.com/acsjournals</a> 
<a href='http://linkedin.com/company/acs-journals'>linkedin.com/company/acs-journals</a>
Speakers in this conversation may have used shortened or informal terms rather than the precise language found in the published article. Please refer to the full text for exact terminology, definitions, and details.
Original music by J. Gilman.

What are the latest advances shaping breast cancer treatment? Dr. Ruth O’Regan, Deputy Editor and Breast Disease Section Editor for Cancer, speaks with Dr. Kevin Kalinsky about his recent commentary highlighting efforts to reduce treatment intensity, the role of biomarkers in personalizing care, and emerging therapies such as antibody–drug conjugates.
Read the featured commentary, “Top advances of the year: Breast cancer”: <a href='https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.70572'>https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.70572</a>
Follow Cancer on social media:
<a href='https://x.com/JournalCancer'>x.com/JournalCancer</a>
<a href='https://www.instagram.com/acsjournals/'>instagram.com/acsjournals</a>
<a href='http://linkedin.com/company/acs-journals'>linkedin.com/company/acs-journals</a>
Speakers in this conversation may have used shortened or informal terms rather than the precise language found in the published article. Please refer to the full text for exact terminology, definitions, and details.
Original music by J. Gilman.

What are the latest advances shaping breast cancer treatment? Dr. Ruth O’Regan, Deputy Editor and Breast Disease Section Editor for Cancer, speaks with Dr. Kevin Kalinsky about his recent commentary highlighting efforts to reduce treatment intensity, the role of biomarkers in personalizing care, and emerging therapies such as antibody–drug conjugates.
Read the featured commentary, “Top advances of the year: Breast cancer”: https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.70572
Follow Cancer on social media:
x.com/JournalCancerinstagram.com/acsjournalslinkedin.com/company/acs-journals
Speakers in this conversation may have used shortened or informal terms rather than the precise language found in the published article. Please refer to the full text for exact terminology, definitions, and details.
Original music by J. Gilman.

Top Advances of the Year: Breast Cancer

Description